Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix H. LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 80.00p 79.00p 81.00p 80.50p 80.00p 80.50p 168,941 08:08:03
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.2 1.7 2.4 32.9 68.35

OptiBiotix Health PLC Director Appointment

11/01/2019 7:00am

UK Regulatory (RNS & others)

Optibiotix H. (LSE:OPTI)
Historical Stock Chart

3 Months : From Dec 2018 to Mar 2019

Click Here for more Optibiotix H. Charts.


RNS Number : 8127M

OptiBiotix Health PLC

11 January 2019

OptiBiotix Health plc


Director Appointment

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, announces that, further to the previous announcement made on 17 December 2018 regarding the appointment of Frédéric Narbel as Managing Director of OptiBiotix's prebiotic division (containing SweetBiotix, OptiBiotic and microbiome modulating technology platforms), the regulatory due diligence process required for a board position has been completed. The text below sets out the required disclosures.

Pursuant to Rule 17 and Schedule 2(g) of the AIM Rules for Companies, the following information is disclosed in respect of Frédéric André Narbel (aged 34):

 Current Appointments                       Appointments in the last 
                                             five years 
 Agropur Inc., Appleton (Wisconsin, USA),   None 
  Succursale de Lancy 

Frédéric Narbel does not currently own any shares in the Company.

There is no further information regarding Mr Narbel required to be disclosed under the AIM Rules.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

For further information, please contact:

 OptiBiotix Health plc                                                
 Stephen O'Hara, Chief Executive                                             Contact via Walbrook 
 Cairn Financial Advisers LLP (NOMAD)                                          Tel: 020 7213 0880 
 Liam Murray / Jo Turner 
   finnCap (Broker)                                                            Tel: 020 7220 0500 
 Geoff Nash/ Scott Mathieson / Kate Bannatyne 
  (Corporate Finance) 
 Camille Gochez (Corporate Broking) 
 Walbrook PR Ltd                                  Tel: 020 7933 8780 or 
 Anna Dunphy                                                                   Mob: 07876 741 001 

About OptiBiotix -

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D program working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit



(END) Dow Jones Newswires

January 11, 2019 02:00 ET (07:00 GMT)

1 Year Optibiotix H. Chart

1 Year Optibiotix H. Chart

1 Month Optibiotix H. Chart

1 Month Optibiotix H. Chart
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20190325 00:08:49